Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NATCO PHARMA vs DISHMAN PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NATCO PHARMA DISHMAN PHARMA NATCO PHARMA/
DISHMAN PHARMA
 
P/E (TTM) x 13.3 30.0 44.5% View Chart
P/BV x 3.5 3.3 104.5% View Chart
Dividend Yield % 0.6 0.7 87.0%  

Financials

 NATCO PHARMA   DISHMAN PHARMA
EQUITY SHARE DATA
    NATCO PHARMA
Mar-23
DISHMAN PHARMA
Mar-16
NATCO PHARMA/
DISHMAN PHARMA
5-Yr Chart
Click to enlarge
High Rs847374 226.1%   
Low Rs502129 389.4%   
Sales per share (Unadj.) Rs148.4197.0 75.3%  
Earnings per share (Unadj.) Rs39.221.2 185.0%  
Cash flow per share (Unadj.) Rs48.234.7 138.8%  
Dividends per share (Unadj.) Rs5.502.00 275.0%  
Avg Dividend yield %0.80.8 102.6%  
Book value per share (Unadj.) Rs267.1179.9 148.5%  
Shares outstanding (eoy) m182.4780.70 226.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x4.51.3 355.8%   
Avg P/E ratio x17.211.9 144.9%  
P/CF ratio (eoy) x14.07.3 193.0%  
Price / Book Value ratio x2.51.4 180.5%  
Dividend payout %14.09.4 148.7%   
Avg Mkt Cap Rs m123,04920,307 605.9%   
No. of employees `000NANA-   
Total wages/salary Rs m4,8675,355 90.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m27,07115,898 170.3%  
Other income Rs m1,285265 484.2%   
Total revenues Rs m28,35616,163 175.4%   
Gross profit Rs m9,1174,103 222.2%  
Depreciation Rs m1,6381,091 150.2%   
Interest Rs m145944 15.4%   
Profit before tax Rs m8,6192,334 369.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,466624 235.1%   
Profit after tax Rs m7,1531,710 418.3%  
Gross profit margin %33.725.8 130.5%  
Effective tax rate %17.026.7 63.6%   
Net profit margin %26.410.8 245.7%  
BALANCE SHEET DATA
Current assets Rs m30,00311,018 272.3%   
Current liabilities Rs m6,8319,517 71.8%   
Net working cap to sales %85.69.4 906.7%  
Current ratio x4.41.2 379.4%  
Inventory Days Days6357 111.4%  
Debtors Days Days1153 3,300.4%  
Net fixed assets Rs m26,57118,787 141.4%   
Share capital Rs m365161 226.1%   
"Free" reserves Rs m48,37314,354 337.0%   
Net worth Rs m48,73814,516 335.8%   
Long term debt Rs m04,189 0.0%   
Total assets Rs m56,57429,805 189.8%  
Interest coverage x60.43.5 1,741.3%   
Debt to equity ratio x00.3 0.0%  
Sales to assets ratio x0.50.5 89.7%   
Return on assets %12.98.9 144.8%  
Return on equity %14.711.8 124.6%  
Return on capital %18.017.5 102.6%  
Exports to sales %024.9 0.0%   
Imports to sales %10.23.7 273.9%   
Exports (fob) Rs mNA3,956 0.0%   
Imports (cif) Rs m2,772594 466.4%   
Fx inflow Rs m17,2564,952 348.5%   
Fx outflow Rs m2,772697 397.9%   
Net fx Rs m14,4844,255 340.4%   
CASH FLOW
From Operations Rs m8,4912,786 304.7%  
From Investments Rs m-4,771-1,529 312.1%  
From Financial Activity Rs m-3,630-941 385.8%  
Net Cashflow Rs m208317 65.7%  

Share Holding

Indian Promoters % 49.7 61.4 81.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 25.0 23.0 108.8%  
FIIs % 13.7 12.0 114.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 50.3 38.6 130.3%  
Shareholders   207,571 52,291 397.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NATCO PHARMA With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Natco Pharma vs Dishman Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Natco Pharma vs Dishman Pharma Share Price Performance

Period Natco Pharma Dishman Pharma S&P BSE HEALTHCARE
1-Day -2.11% 2.87% 1.18%
1-Month -3.19% -2.45% -0.75%
1-Year 72.80% 96.38% 61.82%
3-Year CAGR 4.96% 89.34% 18.16%
5-Year CAGR 10.96% 38.20% 19.79%

* Compound Annual Growth Rate

Here are more details on the Natco Pharma share price and the Dishman Pharma share price.

Moving on to shareholding structures...

The promoters of Natco Pharma hold a 49.7% stake in the company. In case of Dishman Pharma the stake stands at 61.4%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Natco Pharma and the shareholding pattern of Dishman Pharma.

Finally, a word on dividends...

In the most recent financial year, Natco Pharma paid a dividend of Rs 5.5 per share. This amounted to a Dividend Payout ratio of 14.0%.

Dishman Pharma paid Rs 2.0, and its dividend payout ratio stood at 9.4%.

You may visit here to review the dividend history of Natco Pharma, and the dividend history of Dishman Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.